SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-131735
Filing Date
2017-04-21
Accepted
2017-04-21 11:00:34
Documents
7
Period of Report
2017-06-01
Filing Date Changed
2017-04-21
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d296121ddef14a.htm DEF 14A 343085
2 GRAPHIC g296121logo.jpg GRAPHIC 11285
3 GRAPHIC g296121logonew.jpg GRAPHIC 15235
4 GRAPHIC g296121ltrpg1.jpg GRAPHIC 4004
5 GRAPHIC g296121notpg1.jpg GRAPHIC 3882
6 GRAPHIC g296121pc1.jpg GRAPHIC 8999
7 GRAPHIC g296121txpg33.jpg GRAPHIC 3952
  Complete submission text file 0001193125-17-131735.txt   410313
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 17774589
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1